Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27160653)

Published in Am J Transplant on May 10, 2016

Authors

S Karami1, E L Yanik1, L E Moore1, R M Pfeiffer1, G Copeland2, L Gonsalves3, B Y Hernandez4, C F Lynch5, K Pawlish6, E A Engels1

Author Affiliations

1: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Department of Health and Human Services, Bethesda, MD.
2: Michigan Cancer Surveillance Program, Michigan Department of Community Health, Lansing, MI.
3: Connecticut Department of Public Health, Hartford, CT.
4: University of Hawaii Cancer Center, Honolulu, HI.
5: Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA.
6: New Jersey State Cancer Registry, Cancer Epidemiology Services, New Jersey Department of Health, Trenton, NJ.

Articles cited by this

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06

Overdiagnosis in cancer. J Natl Cancer Inst (2010) 10.31

Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99

Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04

Survival advantages of obesity in dialysis patients. Am J Clin Nutr (2005) 3.75

International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol (2014) 3.15

Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40

Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics (2006) 2.13

Hazard function estimation using B-splines. Biometrics (1995) 2.06

Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol (2003) 1.84

Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int (2002) 1.72

An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer (2013) 1.71

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation (2004) 1.68

Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis (2000) 1.68

Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant (2010) 1.65

Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant (2010) 1.64

Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens (2008) 1.59

Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol (2006) 1.58

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities? BJU Int (2012) 1.56

Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int (2006) 1.26

Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology (2005) 1.22

Kidney and bladder cancers among people with AIDS in the United States. J Acquir Immune Defic Syndr (2008) 1.02

End stage and chronic kidney disease: associations with renal cancer. Front Oncol (2012) 0.98

Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients. BJU Int (2009) 0.97

Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. J Am Soc Nephrol (1996) 0.91

De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients. BJU Int (2010) 0.90

Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience. Transplantation (2010) 0.88

Medicare from A to D: what every nephrologist needs to know. Clin J Am Soc Nephrol (2008) 0.84

Renal cell carcinoma: Evolving and emerging subtypes. World J Clin Cases (2013) 0.83

Germline PKHD1 mutations are protective against colorectal cancer. Hum Genet (2011) 0.82

Renal cell carcinoma of native kidneys in renal transplant patients. Curr Opin Urol (2011) 0.79

Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients. J Urol (2011) 0.79

Genetic profiles in renal tumors. Int J Urol (2009) 0.79

Renal cancer associated with acquired cystic disease of the kidney and chronic renal failure. Semin Urol (1989) 0.78

Renal cell carcinoma in acquired cystic kidney disease. Histopathology (2010) 0.78

Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis. Transplant Proc (2011) 0.77

Acquired cystic disease of the kidney: an indication for renal transplantation? Br Med J (Clin Res Ed) (1986) 0.76